Helicobacter pylori grows and multiplies in the gastrointestinal tract (GIT) in about half of the
world's population. The prevalence of diseases associated with this bacterium is steadily
increasing, which makes it necessary to search for optimal therapy aimed at eradication of
this bacterium. Such diseases, for example, include gastric ulcer (GU) and chronic gastritis
(CG). Unfortunately, modern possibilities for eradication therapy do not always make it
possible to cure patients, and relapses often occur if it is cured. Nowadays, a particular …